Category: St. Jude MedicalSyndicate content

Device makers take big writedowns on renal denervation

May 13, 2014 by Brad Perriello

Boston Scientific, Medtronic and Covidien take millions in write-downs on their renal denervation assets after the failure of Medtronic's Symplicity-3 trial.

Device makers take big writedowns on renal denervation

HRS2014: Perforations, deaths temporarily derail St. Jude's E.U. Nanostim study

May 12, 2014 by Arezu Sarvestani

Two perforation-related deaths and 4 additional adverse events temporarily derail enrollment in St. Jude Medical's European Nanostim registry as the company evaluates the patient injuries.

Updated May 12, 2014, at 5:30 p.m. with confirmation from St. Jude Medical.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more

May 12, 2014 by Arezu Sarvestani

Medtech's biggest players release a slew of new reports at this year's Heart Rhythm Society conference, with Medtronic data on preventive shocks for ICD patients, lowered mortality for patients remotely monitored with Boston Scientific's LATITUDE system, and more.

HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HRS2014: St. Jude Medical and the ghost of product recall past

May 12, 2014 by Arezu Sarvestani

Researchers at this year's Heart Rhythm Society conference are still struggling to figure out the best way to manage patients still implanted with St. Jude Medical's recalled Riata defibrillator leads, but the company won some hearts with strong findings for its next-generation Optim-coated devices.

HRS2014: St. Jude and the ghost of product recall past

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

DOJ probes St. Jude | Medtech legal news for the week of May 12, 2014

May 12, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Justice Dept. probes St. Jude for potential False Claims, kickbacks violations; More secret human studies uncovered in Myxo ring inquiry; Medtech manufacturer fleeced Stryker, says former exec; FDA morcellator warning spurs lawsuit against J&J; NuVasive claims win in patent spat with Cadwell Labs

Justice Dept. probes St. Jude for potential False Claims, kickbacks violations

May 6, 2014 by Arezu Sarvestani

Battery wars at HRS2014: And the winner is?

May 10, 2014 by Arezu Sarvestani

The battle over battery life was a big part of this year's Heart Rhythm Society conference, but who came out on top?

Battery wars at HRS2014:

A string of presentations and poster sessions during this week's Heart Rhythm conference pitted device makers against each other in the battle for battery superiority.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HRS2014: St. Jude's lead-free Nanostim pacemaker still looks good at 1 year

May 9, 2014 by Arezu Sarvestani

St. Jude Medical's game-changing Nanostim pacemaker still looks strong in 1-year results from an early study of heart failure patients.

HRS2014: St. Jude's Nanostim still looks good at 1 year

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp